We have direct presence in Europe and Latin America
Almirall
Almirall around the world
Our medicines
Our aim is to improve people's health and wellbeing. We research, develop, produce and market our own R&D and licensed medicines.
This space is reserved for health professionals as it contains information on medicines.
Latest news
- 08/02/2010 Silodosin, indicated for benign prostatic hyperplasia (BPH), has been approved by the European Comm...
- 27/01/2010 Almirall strengthens its focus on the twice-daily dosing of Eklira® in Chronic Obstructive Pulmonar...
- 20/01/2010 The 9th Psychiatry Symposium, organized by Almirall, presents the latest advances in this area
- 07/01/2010 Almirall and Forest announce positive results from the ACCORD COPD I Phase III study of aclidinium ...
Investors and shareholders
We offer the chance of developing a professional career within a sound and expanding company.
Optimized for Internet Explorer